Lung Cancer, Nonsmall Cell, Stage I
Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00062 | Albumin human | 0 | Terminated | 1 |
| DB00958 | Carboplatin | 0 | Terminated | 1 |
| DB01229 | Paclitaxel | 0 | Terminated | 1 |
| DB11595 | Atezolizumab | 1 | Active Not Recruiting | 1 |
| DB11714 | Durvalumab | 1 / 2 | Not Yet Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Unknown Status | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB11714 | Durvalumab | 2 | Recruiting | 4 |
| DB00441 | Gemcitabine | 2 | Completed | 1 |
| DB14865 | Human interleukin-2 | 2 | Completed | 1 |
| DB09053 | Ibrutinib | 2 | Withdrawn | 1 |
| DB15483 | Modified vaccinia ankara | 2 | Completed | 1 |
| DB06132 | Nivolumab | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Completed | 3 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Withdrawn | 1 |
| DB09330 | Osimertinib | 2 | Active Not Recruiting | 1 |
| DB09330 | Osimertinib | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00642 | Pemetrexed | 2 | Completed | 1 |
| DB12257 | Platinum | 2 | Completed | 1 |
| DB14851 | Relatlimab | 2 | Recruiting | 1 |
| DB00605 | Sulindac | 2 | Completed | 1 |
| DB06584 | TG4010 | 2 | Completed | 1 |
| DB05296 | Motexafin lutetium | Not Available | Terminated | 1 |